share_log

HC Wainwright & Co. Downgrades CervoMed to Neutral

HC Wainwright & Co. Downgrades CervoMed to Neutral

HC Wainwright & Co. 將CervoMed評級下調至中立
Benzinga ·  2024/12/17 19:23

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades CervoMed (NASDAQ:CRVO) from Buy to Neutral.

HC Wainwright & Co. 分析師Raghuram Selvaraju將CervoMed (納斯達克:CRVO)的評級從買入下調至中立。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論